Transcription of Guideline for good clinical practice E6(R2)
{{id}} {{{paragraph}}}
1 December 2016. EMA/CHMP/ICH/135/1995. Committee for Human Medicinal Products Guideline for good clinical practice E6(R2). Step 5. Adopted by CHMP for release for consultation 23 July 2015. Start of public consultation 4 August 2015. End of consultation (deadline for comments) 3 February 2016. Final adoption by CHMP 15 December 2016. Date for coming into effect 14 June 2017. 30 Churchill Place Canary Wharf London E14 5EU United Kingdom Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5555. Send a question via our website An agency of the European Union European Medicines Agency, 2017.
Guideline for good clinical practice E6(R2) EMA/CHMP/ICH/135/1995 Page 2/70 Document History First Codification History Date New Codification
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}
TO ICH E11: CLINICAL INVESTIGATION, Guideline, To ich e11: clinical investigation of, Clinical investigation of medicinal products for, Clinical investigation of medicinal products, Clinical guideline, Management of diabetes, GUIDELINE FOR THE CONDUCT OF, Guideline for . the conduct of bioequivalence studies, Investigation, Elevated Blood Lead Investigation Guideline, KDHE, And CAG Clinical Guideline: Management of, CLINICAL, Bioequivalence of medicines, Clinical Pharmacokinetic Studies of Pharmaceuticals